Inventor profile of:

Rainer Boxhammer

City:

Aying

Country:

Germany

Published Applications:

13

Last publication date:

2025-06-19

Top Assignees for applications by Rainer Boxhammer

The entities that hold a legal rights for patent applications filed by inventor Boxhammer Rainer:

Recent patent applications by Boxhammer Rainer

Rainer Boxhammer from Aying, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-19
US20250195646A1
Human necessities

COMBINATIONS AND USES THEREOF

#2 | 2024-01-11
US20240009196A1
Human necessities

COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF

#3 | 2022-09-08
US20220283166A1
Physics

METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS

#4 | 2022-03-24
US20220088197A1
Human necessities

Combinations and uses thereof

#5 | 2020-07-02
US20200206228A1
Human necessities

COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF

#6 | 2019-08-08
US20190241656A1
Chemistry; metallurgy

COMBINATION OF ANTI CD19 ANTIBODY WITH A BCL-2 INHIBITOR AND USES THEREOF

#7 | 2019-06-27
US20190195879A1
Physics

METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS

#8 | 2018-08-16
US20180228893A1
Human necessities

Combinations and uses thereof

#9 | 2018-06-07
US20180153892A1
Human necessities

Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof

#10 | 2018-01-25
US20180022823A1
Chemistry; metallurgy

Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide

#11 | 2016-08-04
US20160222127A1
Chemistry; metallurgy

Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib

#12 | 2015-01-15
US20150017160A1
Human necessities

Combinations and uses thereof

#13 | 2013-11-14
US20130302318A1
Human necessities

Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL

InventorID:

528282 ⎘